Hironobu Suto, Mina Nagao, Hiroyuki Matsukawa, Takuro Fuke, Yasuhisa Ando, Minoru Oshima, Shigeo Takahashi, Toru Shibata, Hideki Kamada, Hideki Kobara, et al. Relationships between postoperative recurrences and standardized uptake value on 18F-fluorodeoxyglucose-positron emission tomography in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma who underwent curative pancreatic resection after neoadjuvant chemoradiotherapy. Pancreatology. 2024
Hironobu Suto, Hiroyuki Matsukawa, Takuro Fuke, Mina Nagao, Yasuhisa Ando, Minoru Oshima, Hiroki Yamana, Hideki Kamada, Hideki Kobara, Hiroyuki Okuyama, et al. Tumor location, clinicopathological features, and perioperative and prognostic outcomes in patients who underwent pancreatic resection following neoadjuvant chemoradiotherapy for resectable pancreatic cancer: A retrospective study. Pancreatology. 2024. 24. 3. 431-436
Hironobu Suto, Takuro Fuke, Hiroyuki Matsukawa, Yasuhisa Ando, Minoru Oshima, Mina Nagao, Shigeo Takahashi, Toru Shibata, Hiroki Yamana, Hideki Kamada, et al. Short- and Long-Term Outcomes of Neoadjuvant Chemoradiotherapy Followed by Pancreatoduodenectomy in Elderly Patients with Resectable and Borderline Resectable Pancreatic Cancer: A Retrospective Study. Journal of Clinical Medicine. 2024. 13. 5. 1216-1216
A phase II study of everolimus in patients with unresectable pancreatic neuroendocrine carcinoma refractory or intolerant to platinum-contained chemotherapy
(ESMO 2018 2018)